We are very excited to launch our new website! Please take a few moments to click around and explore. Best wishes for 2018!
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...